Streetbeat News

HSCS

Heart Test Laboratories, Inc.

https://heartsciences.com

Industry

Medical - Devices

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Open

2.60

Mkt cap

2.4M

Volume

5.1K

High

2.79

P/E Ratio

-0.32

52-wk high

29.00

Low

2.60

Div yield

N/A

52-wk low

2.36

The article highlights significant intraday movements in health care stocks on Friday. Notable gainers include Novo Integrated Sciences (NVOS), Anebulo Pharmaceuticals (ANEB), Annovis Bio (ANVS), Vaccinex (VCNX), Genprex (GNPX), and Purple Biotech (PPBT). Significant losers include Calidi Biotherapeutics (CLDI), Summit Therapeutics (SMMT), Heart Test Laboratories (HSCS), Humacyte (HUMA), Concord Medical Services (CCM), and Pulse Biosciences (PLSE).

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 4:31 pm

Heart Test Laboratories has been granted European Patent Number EP3834729 for its technology titled 'ELECTROCARDIOGRAM-BASED ASSESSMENT OF DIASTOLIC FUNCTION'.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 3:34 pm

HeartSciences (NASDAQ:HSCS) has been granted Indian Patent Application 201817014481 by the Indian Patent Office, adding to its portfolio of 44 granted patents, including nine in the US and 35 internationally.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 1:06 pm

Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) shares fell 14.4% after the company reduced its dividend and lowered its third and fourth-quarter expectations. Other notable stock movements include Fangdd Network Group Ltd. (NASDAQ:DUO) jumping 258.6% and GameStop Corp (NYSE:GME) falling 22.6% after releasing preliminary first-quarter results.

Portfolio Pulse from Avi Kapoor

May 17, 2024 | 6:18 pm

Heart Test Laboratories shares are trading lower following the commencement of its 1-for-100 reverse stock split on a split-adjusted basis.

Portfolio Pulse from Benzinga Newsdesk

May 17, 2024 | 4:49 pm

Heart Test Laboratories has initiated a 1-for-100 reverse stock split, which began trading on a split-adjusted basis on May 17, 2024, on the Nasdaq Capital Market.

Portfolio Pulse from Benzinga Newsdesk

May 17, 2024 | 4:48 pm

US stocks edged higher with the Dow Jones, NASDAQ, and S&P 500 showing slight gains. Applied Materials reported better-than-expected Q2 earnings, boosting its stock. Fangdd Network Group, Akanda Corp, and Crown ElectroKinetics saw significant stock price increases, while Heart Test Laboratories, AmpliTech Group, and GameStop experienced notable declines.

Portfolio Pulse from Avi Kapoor

May 17, 2024 | 1:47 pm

Trading halt status for HSCS was updated at 8:55:00 AM ET. The news and resumption times have been provided.

Portfolio Pulse from Benzinga Newsdesk

May 17, 2024 | 12:55 pm

Akoustis Technologies shares fell by around 18% due to weak quarterly results, missing both earnings and sales estimates. Other stocks moved significantly in Monday's mid-day session, with notable gainers including GameStop, KOSS Corp, and CareCloud, among others, while losers included Barnes & Noble Education and Seritage Growth Properties.

Portfolio Pulse from Avi Kapoor

May 13, 2024 | 5:01 pm

Health care stocks showed significant movement in Monday's intraday session, with notable gainers including CareCloud, Novavax, and Macrogenics, and losers like TransCode Therapeutics and Applied DNA Sciences. Earnings reports influenced several stock movements.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 4:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.